Can-Fite BioPharma (CANF) Curent Deferred Tax Liability (2016 - 2026)

Can-Fite BioPharma (CANF) has 4 years of Curent Deferred Tax Liability data on file, last reported at $974000.0 in Q2 2026.

• For the quarter ending Q2 2026, Curent Deferred Tax Liability changed N/A year-over-year to $974000.0; the trailing twelve-month figure through Jun 2026 stood at $974000.0 (changed N/A YoY), and the FY2025 full-year result was $1.2 million, changed N/A from the prior year.
• Curent Deferred Tax Liability was $974000.0 for Q2 2026 at Can-Fite BioPharma, down from $1.2 million in the prior quarter.
• In the past five years, Curent Deferred Tax Liability ranged from a high of $1.2 million in Q4 2025 to a low of $974000.0 in Q2 2026.